Global market for oncology adjuvants worth $91.7 billion by 2015

The global market for oncology adjuvants was worth an estimated $45.1 billion in 2009. The market is projected to grow to $53 billion in 2010 and nearly $91.7 billion in 2015 at a compound annual growth rate (CAGR) of 11.6% from 2010 to 2015.

Learn about the current oncology adjuvant marketplace in various cancers and get information on each market segment and various forecasts for growth over the next 5 years. Other factors, such as FDA restrictions, government legislation, a cancer’s drug resistance to therapeutics, and/or natural and alternative remedies are also highlighted...

Use this report to:

• Learn about 30 FDA-approved oncology adjuvants with antitumor or tissue protective activity, including pharmaceuticals, immunotherapy, and radiosensitizing/radioprotective adjuvants
• Assess the growth potential of the marketplace for adjuvant technologies in oncology over the next five years
• Understand how factors such as FDA restrictions, government legislation, a cancer’s drug resistance to therapeutics, and/or natural and alternative remedies will influence this market
• Validate marketing and business plans based on an analysis of cancer trends by cancer type, including sales forecasts for each cancer indication though 2015.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.